Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

June 30, 2010

Conditions
Hyponatremia
Interventions
DRUG

Conivaptan

20mg bolus over 30 min, and then as a 20mg infusion over 24 hours for up to 4 days

OTHER

D5

Volume loading dose of D5 followed by an infusion of D5 over 24 hours for up to 4 days - or until the study endpoint of sodium ≥135mEq/L is reached.

Trial Locations (1)

10032

Columbia University Medical Center, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Astellas Pharma Inc

INDUSTRY

lead

Columbia University

OTHER